MN Ovarian Cancer Alliance announces 2019 research funding: 4 Masonic Cancer Center Recipients - MOCA Blog Post
MOCA celebrated 20 years of progress – and new milestones in ovarian cancer research funding – at the MOCA Annual Meeting this week.
This year, MOCA awarded $680,000 in funding to Minnesota and national researchers, putting our total amount of funding at nearly $9 million.
The 2019 MOCA-funded researchers at the Masonic Cancer Center, University of Minnesota include:
- Melissa Geller, MD, MS, University of Minnesota. “IL-15 superagonist ALT 803 maintenance therapy to prevent recurrence of advanced stage ovarian cancer.” $100,000 for one year.
- Emil Lou, MD, PhD, University of Minnesota. “Targeting channels of ovarian tumor cell communication.” $80,000 for one year.
- Reuben Harris, PhD, University of Minnesota. “Diagnosing and targeting APOBEC3B in clear cell ovarian carcinoma.” $100,000 for one year.
- Amy Skubitz, PhD, University of Minnesota. “Verification of a biomarker panel for the early detection of ovarian cancer using serum samples from multiple sources.” $150,000 for one year.
In addition to the 2019 funding, MOCA is also providing $475,000 this year to multi-year grant awards that were funded in 2017 and 2018.
Curious to hear from the researchers themselves? Watch the MOCA Facebook Live video from the event!